Q4 2023 Holdings
Filed 2024-02-14 | 76 holdings | $417.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $43.2M | 484,000 | 10.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $33.4M | 400,000 | 8.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $23.9M | 13,680,554 | 5.7% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $18.4M | 516,341 | 4.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $16.0M | 742,574 | 3.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $15.6M | 123,472 | 3.7% |
| Karuna Therapeutics Inc | COM | 48576A100 | $15.2M | 48,145 | 3.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $14.7M | 511,894 | 3.5% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $13.9M | 102,500 | 3.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $12.7M | 276,739 | 3.1% |
| Merus N V | COM | N5749R100 | $12.5M | 454,870 | 3.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $10.2M | 110,863 | 2.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $10.0M | 686,463 | 2.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.6M | 72,615 | 2.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $8.4M | 67,552 | 2.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $7.4M | 601,032 | 1.8% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.2M | 168,772 | 1.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $7.1M | 492,684 | 1.7% |
| Morphic Holding Inc | COM | 61775R105 | $6.7M | 231,748 | 1.6% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $6.5M | 220,708 | 1.6% |
| Axogen Inc(AXGN) | COM | 05463X106 | $6.4M | 935,894 | 1.5% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $6.2M | 1,447,465 | 1.5% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $5.7M | 193,661 | 1.4% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $5.3M | 245,000 | 1.3% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.3M | 130,175 | 1.3% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $5.3M | 89,387 | 1.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.9M | 449,384 | 1.2% |
| Alector Inc(ALEC) | COM | 014442107 | $4.9M | 609,905 | 1.2% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.6M | 248,217 | 1.1% |
| Atricure Inc(ATRC) | COM | 04963C209 | $4.5M | 125,529 | 1.1% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.4M | 232,717 | 1.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $4.3M | 1,307,407 | 1.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.2M | 709,500 | 1.0% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $4.1M | $4,000,000 | 1.0% |
| Accuray Inc(ARAY) | COM | 004397105 | $3.5M | 1,222,358 | 0.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $3.4M | 449,008 | 0.8% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $3.0M | 74,361 | 0.7% |
| Acelyrin Inc | COM | 00445A100 | $2.8M | 371,200 | 0.7% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $2.7M | 63,300 | 0.6% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $2.6M | 257,653 | 0.6% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.2M | 122,200 | 0.5% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $2.0M | 308,471 | 0.5% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $1.9M | 940,582 | 0.4% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $1.8M | 122,547 | 0.4% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.8M | 778,813 | 0.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $1.7M | 40,742 | 0.4% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $1.7M | 311,169 | 0.4% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $1.7M | 193,000 | 0.4% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $1.7M | 214,885 | 0.4% |
| Spruce Biosciences Inc | COM | 85209E109 | $1.6M | 548,510 | 0.4% |